生物标志物在咽喉反流性疾病中的研究进展

doi:10.6040/j.issn.1673-3770.0.2024.122

Abstract

Abstract: Laryngopharyngeal reflux diease(LPRD)is a common disease in otolaryngology. Currently, the diagnostic criteria for LPRD are not uniform, and clinical manifestations combined with various auxiliary examinations are the main diagnostic methods. Patients with LPRD have different levels of certain substances compared to the normal population, which can cause damage to the pharyngeal mucosa through different mechanisms. There are many biomarkers associated with the onset of LPRD, and in addition to the most common reflux substance, gastric acid, more and more substances have received attention in recent years. These include pepsin, trypsin, neurogenic inflammatory factors, bile acids, tight junction proteins, carbonic anhydrase, mucin, MMP-7 and cell cadherin. Biomarkers have high specificity sensitivity and efficiency, which can reduce the use of diagnostic equipment such as laryngoscopy and pH impedance monitoring. Therefore, the establishment of an LPRD biomarker diagnostic system can help make LPRD diagnosis more convenient and accurate. Here is a summary of LPRD-related biomarkers and a review of their research progress in the diagnosis and treatment of LPRD.

Key words: Laryngopharyngeal Reflux, Biomarkers, Reflux substances, Neurogenic factors, Epithelial structure related proteins

CLC Number:

R766.5

ZHANG Shan, CHEN Qiu, ZHOU Fangwei, MA Yifei. Research progress of biomarkers in laryngopharyngeal reflux disease[J].Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(6): 46-54.

References

[1] Lechien JR, Schindler A, De Marrez LG, et al. Instruments evaluating the clinical findings of laryngopharyngeal reflux: a systematic review[J]. Laryngoscope, 2019, 129(3): 720-736. doi:10.1002/lary.27537
[2] Sereg-Bahar M, Jerin A, Jansa R, et al. Pepsin and bile acids in saliva in patients with laryngopharyngeal reflux - a prospective comparative study[J]. Clin Otolaryngol, 2015, 40(3): 234-239. doi:10.1111/coa.12358
[3] Lechien JR, Finck C, Khalife M, et al. Change of signs, symptoms and voice quality evaluations throughout a 3- to 6-month empirical treatment for laryngopharyngeal reflux disease[J]. Clin Otolaryngol, 2018, 43(5): 1273-1282. doi:10.1111/coa.13140
[4] 徐志宇, 刘旭, 陈世彩, 等. 咽喉反流性疾病的发病机制及其与耳鼻咽喉疾病相关性研究进展[J]. 听力学及言语疾病杂志, 2022, 30(6): 587-590. doi:10.3969/j.issn.1006-7299.2022.06.004
[5] Lechien JR, Chiesa-Estomba CM, Calvo Henriquez C, et al. Laryngopharyngeal reflux, gastroesophageal reflux and dental disorders: a systematic review[J]. PLoS One, 2020, 15(8): e0237581. doi:10.1371/journal.pone.0237581
[6] Lechien J R, Saussez S, Nacci A, et al. Association between laryngopharyngeal reflux and benign vocal folds lesions: A systematic review[J]. Laryngoscope, 2019,129(9):E329-E341. doi:10.1002/lary.27932
[7] 赵博, 杨启梅, 王鑫, 等. 咽喉反流与分泌性中耳炎的相关研究进展[J]. 听力学及言语疾病杂志, 2018, 26(6): 681-684. doi:10.3969/j.issn.1006-7299.2018.06.028
[8] Lechien JR. Personalized treatments based on laryngopharyngeal reflux patient profiles: a narrative review[J]. J Pers Med, 2023, 13(11): 1567. doi:10.3390/jpm13111567
[9] 郎永耀, 杨云, 刘晴, 等. 咽喉反流性疾病的影响因素及治疗效果分析[J]. 山东大学耳鼻喉眼学报, 2019, 33(3): 119-123. doi:10.6040/j.issn.1673-3770.0.2018.472 LANG Yongyao, YANG Yun, LIU Qing, et al. Analysis of influencing factors and observation of therapeutic effects in patients with laryngopharyngeal reflux disease[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(3): 119-123. doi:10.6040/j.issn.1673-3770.0.2018.472
[10] Lechien Jerome R,Saussez Sven,Karkos Petros D.Laryngopharyngeal reflux disease: clinical presentation, diagnosis and therapeutic challenges in 2018[J].Curr Opin Otolaryngol Head Neck Surg, 2018, 26: 392-402.doi: 10.1097/MOO.0000000000000486.
[11] Brown J, Shermetaro C. Laryngopharyngeal Reflux[M].Treasure Island(FL): StatPearls Publishing,2024,Jan. PMID: 30137832.
[12] McCormick CA, Samuels TL, Battle MA, et al. H+/K+ATPase expression in the larynx of laryngopharyngeal reflux and laryngeal cancer patients[J]. Laryngoscope, 2021, 131(1): 130-135. doi:10.1002/lary.28643
[13] Becker V, Bajbouj M, Waller K, et al. Clinical trial: persistent gastro-oesophageal reflux symptoms despite standard therapy with proton pump inhibitors-a follow-up study of intraluminal-impedance guided therapy[J]. Aliment Pharmacol Ther, 2007, 26(10): 1355-1360. doi:10.1111/j.1365-2036.2007.03529.x
[14] Becker V, Drabner R, Graf S, et al. New aspects in the pathomechanism and diagnosis of the laryngopharyngeal reflux-clinical impact of laryngeal proton pumps and pharyngeal pH metry in extraesophageal gastroesophageal reflux disease[J]. World J Gastroenterol, 2015, 21(3): 982-987. doi:10.3748/wjg.v21.i3.982
[15] Li YD, Xu GF, Zhou BD, et al. Effects of acids, pepsin, bile acids, and trypsin on laryngopharyngeal reflux diseases: physiopathology and therapeutic targets[J]. Eur Arch Otorhinolaryngol, 2022, 279(6): 2743-2752. doi:10.1007/s00405-021-07201-w
[16] 郑彦焱, 颜冬惠, 陈十燕, 等. 胃蛋白酶在不同pH条件下对咽喉黏膜上皮的作用[J/OL]. 听力学及言语疾病杂志,2024:1-5(2024-01-15). https://kns.cnki.net/kcms/detail/42.1391.R.20240111.1707.008.html. ZHENG Yanyan, YAN Donghui, CHEN Shiyan, et al. The effects of pepsin on the mucosal epithelium of the laryngopharynx under different pH condition[J/OL]. Journal of Audiology and Speech Pathology, 2024: 1-5(2024-01-15). https://kns.cnki.net/kcms/detail/42.1391.R.20240111.1707.008.html.
[17] 李进让. 咽喉反流性疾病规范化诊断和治疗[J]. 中国耳鼻咽喉头颈外科, 2015, 22(9): 435-437. doi:10.16066/j.1672-7002.2015.09.001
[18] Formánek M, Jan catová D,Komínek P et al. Laryngopharyngeal reflux and herpes simplex virus type 2 are possible risk factors for adult-onset recurrent respiratory papillomatosis(prospective case-control study)[J].Clin Otolaryngol,2017,42(3):597-601. doi: 10.1111/coa.12779
[19] Zub ci c Ž, Mendeš T, V ceva A, et al. Presence of pepsin in laryngeal tissue and saliva in benign and malignant neoplasms[J]. Biosci Rep, 2020, 40(11): BSR20200216. doi:10.1042/BSR20200216
[20] 陶艳丽, 苑铁君. 唾液胃蛋白酶检测在反流性咽喉炎诊断中的价值[J]. 山东大学耳鼻喉眼学报, 2018, 32(6): 52-55. doi:10.6040/j.issn.1673-3770.0.2018.219 TAO Yanli, YUAN Tiejun. Diagnostic value of detection of pepsin in the saliva for laryngopharyngeal reflux[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2018, 32(6): 52-55. doi:10.6040/j.issn.1673-3770.0.2018.219
[21] Hurley BP, Jugo RH, Snow RF, et al. Pepsin triggers neutrophil migration across acid damaged lung epithelium[J]. Sci Rep, 2019, 9(1): 13778. doi:10.1038/s41598-019-50360-4
[22] Gtari W, Bey H, Aschi A, et al. Impact of macromolecular crowding on structure and properties of pepsin and trypsin[J]. Mater Sci Eng C Mater Biol Appl, 2017, 72: 98-105. doi:10.1016/j.msec.2016.11.046
[23] Kowalik K, Krzeski A. The role of pepsin in the laryngopharyngeal reflux[J]. Otolaryngol Pol, 2017, 71(6): 7-13. doi:10.5604/01.3001.0010.7194
[24] Samuels TL, Zimmermann MT, Zeighami A, et al. RNA sequencing reveals cancer-associated changes in laryngeal cells exposed to non-acid pepsin[J]. Laryngoscope, 2021, 131(1): 121-129. doi:10.1002/lary.28636
[25] Tan JJ, Wang L, Mo TT, et al. Pepsin promotes IL-8 signaling-induced epithelial–mesenchymal transition in laryngeal carcinoma[J]. Cancer Cell Int, 2019, 19(1): 64. doi:10.1186/s12935-019-0772-7
[26] Johnston N, Yan JC, Hoekzema CR, et al. Pepsin promotes proliferation of laryngeal and pharyngeal epithelial cells[J]. Laryngoscope, 2012, 122(6): 1317-1325. doi:10.1002/lary.23307
[27] Wang CP, Wang CC, Lien HC, et al. Saliva pepsin detection and proton pump inhibitor response in suspected laryngopharyngeal reflux[J]. Laryngoscope, 2019, 129(3): 709-714. doi:10.1002/lary.27502
[28] 万苡辰, 闫燕, 马芙蓉. 咽喉反流的机制及诊断方法[J]. 听力学及言语疾病杂志, 2013, 21(2): 200-204. doi:10.3969/j.issn.1006-7299.2013.02.032
[29] Landry V, Coburn P, Kost K, et al. Diagnostic accuracy of liquid biomarkers in airway diseases: toward point-of-care applications[J]. Front Med, 2022, 9: 855250. doi:10.3389/fmed.2022.855250
[30] 高竞逾, 罗仁婧, 阮标, 等. 胃蛋白酶免疫组织化学与胃蛋白酶检测试剂盒在咽喉反流诊断中的一致性分析[J]. 临床耳鼻咽喉头颈外科杂志, 2023, 37(2): 97-102, 106. doi:10.13201/j.issn.2096-7993.2023.02.004 GAO Jingyu, LUO Renjing, RUAN Biao, et al. Consistency analysis of pepsin immunohistochemistry and pepsin test box in the diagnosis of laryngopharyngeal reflux[J]. Journal of Clinical Otorhinolaryngology Head and Neck Surgery, 2023, 37(2): 97-102, 106. doi:10.13201/j.issn.2096-7993.2023.02.004
[31] Saritas Yuksel E, Hong SK, Strugala V, et al. Rapid salivary pepsin test: blinded assessment of test performance in gastroesophageal reflux disease[J]. Laryngoscope, 2012, 122(6): 1312-1316. doi:10.1002/lary.23252
[32] Bor S, Capanoglu D, Vardar R, et al. Validation of peptest^TM in patients with gastro-esophageal reflux disease and laryngopharyngeal reflux undergoing impedance testing[J]. J Gastrointestin Liver Dis, 2019, 28(4): 383-387. doi:10.15403/jgld-335
[33] Na SY, Kwon OE, Lee YC, et al. Optimal timing of saliva collection to detect pepsin in patients with laryngopharyngeal reflux[J]. Laryngoscope, 2016, 126(12): 2770-2773. doi:10.1002/lary.26018
[34] Klimara MJ, Johnston N, Samuels TL, et al. Correlation of salivary and nasal lavage pepsin with MII-pH testing[J]. Laryngoscope, 2020, 130(4): 961-966. doi:10.1002/lary.28182
[35] Jing WY, Luo WL, Lou L. Diagnostic utility of salivary pepsin in laryngopharyngeal reflux: a systematic review and meta-analysis[J]. Braz J Otorhinolaryngol, 2023, 89(2): 339-347. doi:10.1016/j.bjorl.2022.10.050
[36] Pearson JP, Parikh S, Orlando RC, et al. Review article: reflux and its consequences: the laryngeal, pulmonary and oesophageal manifestations. Conference held in conjunction with the 9th International Symposium on Human Pepsin(ISHP)Kingston-upon-Hull, UK, 21-23 April 2010[J]. Aliment Pharmacol Ther, 2011, 33(1): 1-71. doi:10.1111/j.1365-2036.2011.04581.x
[37] Naito Y, Uchiyama K, Kuroda M, et al. Role of pancreatic trypsin in chronic esophagitis induced by gastroduodenal reflux in rats[J]. J Gastroenterol, 2006, 41(3): 198-208. doi:10.1007/s00535-005-1742-5
[38] Tanaka Y, Ihara E, Hirano K, et al. Trypsin-induced biphasic regulation of tone in the porcine lower esophageal sphincter[J]. Eur J Pharmacol, 2015, 752: 97-105. doi:10.1016/j.ejphar.2015.02.008
[39] Bai XP, Tanaka Y, Ihara E, et al. Trypsin induces biphasic muscle contraction and relaxation via transient receptor potential vanilloid 1 and neurokinin receptors 1/2 in porcine esophageal body[J]. Eur J Pharmacol, 2017, 797: 65-74. doi:10.1016/j.ejphar.2017.01.004
[40] Cao J, Zhang LH, Liu YJ, et al. Properties of a novel animal model of LPRD[J]. J Voice, 2021, 35(5): P805.e17-805.e26. doi:10.1016/j.jvoice.2020.01.021
[41] Silva RO, Bingana RD, Sales TMAL, et al. Role of TRPV1 receptor in inflammation and impairment of esophageal mucosal integrity in a murine model of nonerosive reflux disease[J]. Neurogastroenterol Motil, 2018: e13340. doi:10.1111/nmo.13340
[42] Suzuki N, Mihara H, Nishizono H, et al. Protease-activated receptor-2 up-regulates transient receptor potential vanilloid 4 function in mouse esophageal keratinocyte[J]. Dig Dis Sci, 2015, 60(12): 3570-3578. doi:10.1007/s10620-015-3822-6
[43] De Corso E, Baroni S, Agostino S, et al. Bile acids and total bilirubin detection in saliva of patients submitted to gastric surgery and in particular to subtotal Billroth II resection[J]. Ann Surg, 2007, 245(6): 880-885. doi:10.1097/01.sla.0000255574.22821.a1
[44] Wang L, Liu X, Liu YL, et al. Correlation of pepsin-measured laryngopharyngeal reflux disease with symptoms and signs[J]. Otolaryngol Head Neck Surg, 2010, 143(6): 765-771. doi:10.1016/j.otohns.2010.08.018
[45] Fiorucci S, Distrutti E, di Matteo F, et al. Circadian variations in gastric acid and pepsin secretion and intragastric bile acid in patients with reflux esophagitis and in healthy controls[J]. Am J Gastroenterol, 1995, 90(2): 270-276
[46] Sereg-Bahar M, Jerin A, Jansa R, et al. Pepsin and bile acids in saliva in patients with laryngopharyngeal reflux - a prospective comparative study[J]. Clin Otolaryngol, 2015, 40(3): 234-239. doi:10.1111/coa.12358
[47] De Corso E, Baroni S, Salonna G, et al. Impact of bile acids on the severity of laryngo-pharyngeal reflux[J]. Clin Otolaryngol, 2021, 46(1): 189-195. doi:10.1111/coa.13643
[48] Laird JM, Olivar T, Roza C, et al. Deficits in visceral pain and hyperalgesia of mice with a disruption of the tachykinin NK1 receptor gene[J]. Neuroscience, 2000, 98(2): 345-352. doi:10.1016/s0306-4522(00)00148-2
[49] Ali MS, Parikh S, Chater P, et al. Bile acids in laryngopharyngeal refluxate: will they enhance or attenuate the action of pepsin?[J]. Laryngoscope, 2013, 123(2): 434-439. doi:10.1002/lary.23619
[50] Sereg-Bahar M, Jerin A, Hocevar-Boltezar I. Higher levels of total pepsin and bile acids in the saliva as a possible risk factor for early laryngeal cancer[J]. Radiol Oncol, 2015, 49(1): 59-64. doi:10.2478/raon-2014-0020
[51] Vageli DP, Doukas SG, Doukas PG, et al. Bile reflux and hypopharyngeal cancer(Review)[J]. Oncol Rep, 2021, 46(5): 244. doi:10.3892/or.2021.8195
[52] Galli J, Calò L, Agostino S, et al. Bile reflux as possible risk factor in laryngopharyngeal inflammatory and neoplastic lesions[J]. Acta Otorhinolaryngol Ital, 2003, 23(5): 377-382
[53] De Corso E, Baroni S, Agostino S, et al. Bile acids and total bilirubin detection in saliva of patients submitted to gastric surgery and in particular to subtotal Billroth II resection[J]. Ann Surg, 2007, 245(6): 880-885. doi:10.1097/01.sla.0000255574.22821.a1
[54] 王刚,林春兰,刘蔓林,等.咽喉反流性疾病中SP、NK-1R、IL-8、PGP9.5的表达及意义[J].听力学及言语疾病杂志,2022, 30(6): 582-586. doi:10.3969/i.issn.1006-7299.2022.06.003 WANG Gang, LIN Chunlan, LIU Manlin, et al. Expression and Significance of SP, NK-1R, IL-8, PGP9.5 in Laryngopharyngeal Reflux Disease[J]. Journal of Audiology and Speech Pathology, 2022, 30(6): 582-586. doi:10.3969/i.issn.1006-7299.2022.06.003
[55] 孙建梅, 刘彤彤, 唐宗湘. 神经源性炎症痛的分子机制及研究进展[J]. 中国疼痛医学杂志, 2022, 28(7): 486-493. doi:10.3969/j.issn.1006-9852.2022.07.003 SUN Jianmei, LIU Tongtong, TANG Zongxiang. Molecular mechanism and research progress of neurogenic inflammatory pain[J]. Chinese Journal of Pain Medicine, 2022, 28(7): 486-493. doi:10.3969/j.issn.1006-9852.2022.07.003
[56] Wood JM, Hussey DJ, Woods CM, et al. Biomarkers and laryngopharyngeal reflux[J]. J Laryngol Otol, 2011, 125(12): 1218-1224. doi:10.1017/S0022215111002234
[57] Chen W, Zhang Y, Cheng Y, et al. The role of NF-κB signaling pathway in laryngeal leukoplakia recurrent with laryngeal reflux[J]. Chin J Otorhinolaryngol Head Neck Surg, 2018, 53(8): 597-603. doi:10.3760/cma.j.issn.1673-0860.2018.08.008
[58] 曹杰, 张立红, 王文伦, 等. 白细胞介素-8在兔咽喉反流中的作用[J]. 中国耳鼻咽喉颅底外科杂志, 2020, 26(3): 278-282. doi:10.11798/j.issn.1007-1520.202003010 CAO Jie, ZHANG Lihong, WANG Wenlun, et al. A preliminary study on the role of interleukin-8(IL-8)in laryngopharyngeal reflux of rabbits[J]. Chinese Journal of Otorhinolaryngology-Skull Base Surgery, 2020, 26(3): 278-282. doi:10.11798/j.issn.1007-1520.202003010
[59] 李明航, 刘海林, 刁俊玲, 等. 紧密连接蛋白Claudin-3的研究进展[J]. 现代医药卫生, 2022, 38(11): 1896-1899. doi:10.3969/j.issn.1009-5519.2022.11.022
[60] Zeissig S, Bürgel N, Günzel D, et al. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn’s disease[J]. Gut, 2007, 56(1): 61-72. doi:10.1136/gut.2006.094375
[61] Oguro M, Koike M, Ueno T, et al. Dissociation and dispersion of claudin-3 from the tight junction could be one of the most sensitive indicators of reflux esophagitis in a rat model of the disease[J]. J Gastroenterol, 2011, 46(5): 629-638. doi:10.1007/s00535-011-0390-1
[62] Björkman EVC, Edebo A, Oltean M, et al. Esophageal barrier function and tight junction expression in healthy subjects and patients with gastroesophageal reflux disease: functionality of esophageal mucosa exposed to bile salt and trypsin in vitro[J]. Scand J Gastroenterol, 2013, 48(10): 1118-1126. doi:10.3109/00365521.2013.828772
[63] Xu XB, Hu Y, Wang Y, et al. Expression of claudin-3 in the esophagus and larynx of rat reflux model[J]. Auris Nasus Larynx, 2014, 41(6): 539-542. doi:10.1016/j.anl.2014.05.011
[64] Meloni M, Buratti P, Carriero F, et al. In vitro modelling of barrier impairment associated with gastro-oesophageal reflux disease(GERD)[J]. Clin Exp Gastroenterol, 2021, 14: 361-373. doi:10.2147/CEG.S325346
[65] Okimoto K, Arai M, Ishigami H, et al. A prospective study of eosinophilic esophagitis and the expression of tight junction proteins in patients with gastroesophageal reflux disease symptoms[J]. Gut Liver, 2018, 12(1): 30-37. doi:10.5009/gnl16600
[66] 李秋霞, 罗茂林, 李茹柳, 等. 紧密连接蛋白ZO-1研究概述[J]. 广州中医药大学学报, 2007, 24(6): 523-526. doi:10.3969/j.issn.1007-3213.2007.06.024
[67] Neumann H, Mönkemüller K, Fry LC, et al. Intercellular space volume is mainly increased in the basal layer of esophageal squamous epithelium in patients with GERD[J]. Dig Dis Sci, 2011, 56(5): 1404-1411. doi:10.1007/s10620-010-1458-0
[68] Orlando LA, Orlando RC. Dilated intercellular spaces as a marker of GERD[J]. Curr Gastroenterol Rep, 2009, 11(3): 190-194. doi:10.1007/s11894-009-0030-6
[69] 吴昆旻, 李泽卿, 朱春晖, 等. 紧密连接蛋白在声带白斑伴咽喉反流患者声带黏膜中的表达[J]. 中国耳鼻咽喉颅底外科杂志, 2017, 23(6): 541-545. doi:10.11798/j.issn.1007-1520.201706009 WU Kunmin, LI Zeqing, ZHU Chunhui, et al. Expressions of tight junction proteins in vocal mucosa of patients suffering from vocal leukoplakia accompanied with laryngopharyngeal reflux[J]. Chinese Journal of Otorhinolaryngology-Skull Base Surgery, 2017, 23(6): 541-545. doi:10.11798/j.issn.1007-1520.201706009
[70] Gill GA, Buda A, Moorghen M, et al. Characterisation of adherens and tight junctional molecules in normal animal larynx; determining a suitable model for studying molecular abnormalities in human laryngopharyngeal reflux[J]. J Clin Pathol, 2005, 58(12): 1265-1270. doi:10.1136/jcp.2004.016972
[71] 郝梅, 蒋兴旺, 陈浩, 等. 睡眠剥夺大鼠喉上皮细胞屏障功能改变在咽喉反流发病机制中的作用[J]. 听力学及言语疾病杂志, 2022, 30(6): 577-581. doi:10.3969/j.issn.1006-7299.2022.06.002 HAO Mei, JIANG Xingwang, CHEN Hao, et al. The role of barrier function of laryngeal epithelial cells in the pathogenesis of laryngopharyngeal reflux in sleep deprived rats[J]. Journal of Audiology and Speech Pathology, 2022, 30(6): 577-581. doi:10.3969/j.issn.1006-7299.2022.06.002
[72] Campagnolo AM, Priston J, Thoen RH, et al. Laryngopharyngeal reflux: diagnosis, treatment, and latest research[J]. Int Arch Otorhinolaryngol, 2014, 18(2): 184-191. doi:10.1055/s-0033-1352504
[73] Johnston N, Dettmar PW, Bishwokarma B, et al. Activity/stability of human pepsin: implications for reflux attributed laryngeal disease[J]. Laryngoscope, 2007, 117(6): 1036-1039. doi:10.1097/MLG.0b013e31804154c3
[74] Johnston N, Knight J, Dettmar PW, et al. Pepsin and carbonic anhydrase isoenzyme III as diagnostic markers for laryngopharyngeal reflux disease[J]. Laryngoscope, 2004, 114(12): 2129-2134. doi:10.1097/01.mlg.0000149445.07146.03
[75] Johnston N, Bulmer D, Gill GA, et al. Cell biology of laryngeal epithelial defenses in health and disease: further studies[J]. Ann Otol Rhinol Laryngol, 2003, 112(6): 481-491. doi:10.1177/000348940311200601
[76] Im NR, Lee DY, Kim B, et al. Role of matrix metalloproteinases 7 in the pathogenesis of laryngopharyngeal reflux: decreased E-cadherin in acid exposed primary human pharyngeal epithelial cells[J]. Int J Mol Sci, 2019, 20(21): 5276. doi:10.3390/ijms20215276
[77] Im NR, Kim B, Jung KY, et al. Correction to: matrix metalloproteinase-7 induces E-cadherin cleavage in acid-exposed primary human pharyngeal epithelial cells via the ROS/ERK/c-Jun pathway[J]. J Mol Med, 2022, 100(7): 1091. doi:10.1007/s00109-022-02212-4
[78] Lechien JR, Mouawad F, Bobin F, et al. Review of management of laryngopharyngeal reflux disease[J]. Eur Ann Otorhinolaryngol Head Neck Dis, 2021, 138(4): 257-267. doi:10.1016/j.anorl.2020.11.002

Metrics

Viewed

Full text

Abstract

Cited

Shared

Discussed

Comments

Recommended 0

No Suggested Reading articles found!

Research progress of biomarkers in laryngopharyngeal reflux disease

PDF (PC)

Abstract

Cite this article

share this article

References

Related Articles 15

Metrics

Comments

Recommended 0

[1]	WU Wei, WANG Lei, CHEN Sheng, LI Lianyong, WANG Gang. Multidisciplinary research and advances in gastro-oesophageal reflux disease [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(6): 1-14.
[2]	LIU Lianlian, LI Jinrang. Obstructive sleep apnea and laryngopharyngeal reflux [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(6): 15-22.
[3]	ZHANG Li, ZHANG Mengru, Alimire Aierken, QIU Zhongmin. Role of pharyngeal reflux in common respiratory diseases [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(6): 23-29.
[4]	HU Zhiwei, CHEN Dong, YANG Dong, WU Jimin. Diagnosis and treatment of gastroesophageal airway reflux disease: based on related consensus and guidelines from 2020 to 2024 [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(6): 30-38.
[5]	ZHAO Jianing, CUI Yuanxin, WANG Dan, ZHAO Ming. Exploration of the relationship between laryngopharyngeal reflux and recurrent respiratory papilloma and its mechanism [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(6): 39-45.
[6]	YANG Min, ZHU Xiaoyan, WANG Xu. Progress in metabolomics research in sensorineural hearing loss [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(2): 113-121.
[7]	WANG Lu, ZHANG Yunyun, GUO Hua, CUI Xiaochuan. Application value of lipid metabolism markers for the early screening of Alzheimer's disease in obstructive sleep apnea patients [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(6): 68-74.
[8]	WANG Lei, LI Baowei, WANG Gang, LIU Hongdan, HAN Haolun, ZHANG Xiaoli, WU Wei. A preliminary study on nocturnal alkali reflux in OSAHS patients [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(6): 75-79.
[9]	ZHANG Zhuping, YE Qi, GUO Bei, LIN Ling. Diagnostic utility of folate receptor-positive circulating tumor cells in patients with laryngeal squamous cell carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(5): 50-53.
[10]	ZHOU Xiaoqing, YAN Yajie, LI Yingchun. Treatment of hoarseness based on physiological function of the liver [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(5): 74-79.
[11]	HAO Hong, CHEN Gang, WANG Lin’e. Key candidate genes associated with the molecular mechanisms of adenoid cystic carcinoma identified by bioinformatics [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(5): 99-106.
[12]	SHAO Na, ZHANG Qingqing, LIU Xiaohong, XIE Meng, GUO Ruixin, MA Sijing, LIU Haiqin, REN Xiaoyong, LUO Huanan. Effects of Helicobacter pylori infection on salivary pepsin concentration in patients with symptomatic laryngopharyngeal reflux [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(6): 89-95.
[13]	QIN Ming, SUN Zhanwei, WANG Weiwei, LI Shichao, WU Tianyi, WANG Guangke. Efficacy of alkaline isotonic saline in laryngopharyngeal reflux symptom-positive or finding score-positive patients with chronic rhinosinusitis following endoscopic sinus surgery [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 147-153.
[14]	ZENG Xianting, WANG Guangke, SUN Zhanwei, WU Tianyi, LI Shichao, WANG Weiwei. Postoperative efficacy of proton pump inhibitor in the treatment of difficult-to-treat rhinosinusitis with laryngopharyngeal reflux [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 189-194.
[15]	WU Dipanpan, CUI Xinhua, GUO Ying, GENG Bo, GAO Fangfang, LIANG Hui. Narrow band imaging might contribute to the diagnosis of laryngopharyngeal reflux [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(3): 31-36.